Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19950011rdf:typepubmed:Citationlld:pubmed
pubmed-article:19950011lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:19950011lifeskim:mentionsumls-concept:C0012544lld:lifeskim
pubmed-article:19950011lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:19950011pubmed:dateCreated2009-12-1lld:pubmed
pubmed-article:19950011pubmed:abstractTextAfter decades of successful clinical use, the exact molecular mechanisms by which the anti-resorptive bisphosphonate drugs (BPs) exert their effects are now being revealed. In addition to their anti-resorptive effects, it is now apparent that nitrogen-containing BPs (N-BPs) have immunomodulatory properties. Specifically, these drugs activate immune cells called gamma, delta T lymphocytes. In this chapter we discuss the mechanism of gamma, delta T cell activation by N-BPs and propose that N-BPs may provide a safe and effective means for manipulating gamma,delta T cell activity in future immunotherapeutic approaches.lld:pubmed
pubmed-article:19950011pubmed:languageenglld:pubmed
pubmed-article:19950011pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19950011pubmed:citationSubsetIMlld:pubmed
pubmed-article:19950011pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19950011pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19950011pubmed:statusMEDLINElld:pubmed
pubmed-article:19950011pubmed:issn0065-2598lld:pubmed
pubmed-article:19950011pubmed:authorpubmed-author:ThompsonKeith...lld:pubmed
pubmed-article:19950011pubmed:authorpubmed-author:RogersMichael...lld:pubmed
pubmed-article:19950011pubmed:authorpubmed-author:MönkkönenJukk...lld:pubmed
pubmed-article:19950011pubmed:authorpubmed-author:MönkkönenHann...lld:pubmed
pubmed-article:19950011pubmed:authorpubmed-author:RoelofsAnke...lld:pubmed
pubmed-article:19950011pubmed:authorpubmed-author:JauhiainenMar...lld:pubmed
pubmed-article:19950011pubmed:issnTypePrintlld:pubmed
pubmed-article:19950011pubmed:volume658lld:pubmed
pubmed-article:19950011pubmed:ownerNLMlld:pubmed
pubmed-article:19950011pubmed:authorsCompleteYlld:pubmed
pubmed-article:19950011pubmed:pagination11-20lld:pubmed
pubmed-article:19950011pubmed:meshHeadingpubmed-meshheading:19950011...lld:pubmed
pubmed-article:19950011pubmed:meshHeadingpubmed-meshheading:19950011...lld:pubmed
pubmed-article:19950011pubmed:meshHeadingpubmed-meshheading:19950011...lld:pubmed
pubmed-article:19950011pubmed:meshHeadingpubmed-meshheading:19950011...lld:pubmed
pubmed-article:19950011pubmed:meshHeadingpubmed-meshheading:19950011...lld:pubmed
pubmed-article:19950011pubmed:meshHeadingpubmed-meshheading:19950011...lld:pubmed
pubmed-article:19950011pubmed:meshHeadingpubmed-meshheading:19950011...lld:pubmed
pubmed-article:19950011pubmed:meshHeadingpubmed-meshheading:19950011...lld:pubmed
pubmed-article:19950011pubmed:year2010lld:pubmed
pubmed-article:19950011pubmed:articleTitleActivation of ?? T cells by bisphosphonates.lld:pubmed
pubmed-article:19950011pubmed:affiliationBone and Musculoskeletal Research Programme, Institute of Medical Sciences, University of Aberdeen, Foresterhill, AB25 2ZD, Aberdeen, UK. k.thompson@abdn.ac.uklld:pubmed
pubmed-article:19950011pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19950011lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19950011lld:pubmed